Madrigal Pharmaceuticals, Inc.

MDGL · Healthcare

$538.71

Markedsværdi: 12.45B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Madrigal Pharmaceuticals, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire2. sep. 2026, 12.00

Madrigal Pharmaceuticals to Participate in the  2026 Cantor Global Healthcare Conference

Motley Fool25. aug. 2026, 16.20

Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off

GlobeNewswire20. aug. 2026, 20.05

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

MarketBeat15. aug. 2026, 09.01

Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands